Chong Kun Dang Pharmaceutical (185750) - Total Liabilities

Latest as of September 2025: ₩576.36 Billion KRW ≈ $390.59 Million USD

Based on the latest financial reports, Chong Kun Dang Pharmaceutical (185750) has total liabilities worth ₩576.36 Billion KRW (≈ $390.59 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash flow conversion of Chong Kun Dang Pharmaceutical to assess how effectively this company generates cash.

Chong Kun Dang Pharmaceutical - Total Liabilities Trend (2016–2024)

This chart illustrates how Chong Kun Dang Pharmaceutical's total liabilities have evolved over time, based on quarterly financial data. Check Chong Kun Dang Pharmaceutical liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Chong Kun Dang Pharmaceutical Competitors by Total Liabilities

The table below lists competitors of Chong Kun Dang Pharmaceutical ranked by their total liabilities.

Company	Country	Total Liabilities
Cementos Pacasmayo S.A.A F:EPCC	Germany	€1.91 Billion
Era Co Ltd SHE:002641	China	CN¥2.73 Billion
Guangdong Chant Group Inc SHE:002616	China	CN¥7.51 Billion
Anshan Senyuan Road Bridge SHE:300210	China	CN¥587.19 Million
Shaanxi Construction Machinery Co Ltd SHG:600984	China	CN¥11.18 Billion
Renta 4 Banco S.A MC:R4	Spain	€2.38 Billion
Sonata Software Limited NSE:SONATSOFTW	India	Rs28.37 Billion
Guangdong Senssun Weighing Apparatus Group Ltd SHE:002870	China	CN¥6.11 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Chong Kun Dang Pharmaceutical's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Chong Kun Dang Pharmaceutical market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.89	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.61	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.38	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Chong Kun Dang Pharmaceutical's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Chong Kun Dang Pharmaceutical (2016–2024)

The table below shows the annual total liabilities of Chong Kun Dang Pharmaceutical from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩562.39 Billion ≈ $381.12 Million	-4.16%
2023-12-31	₩586.79 Billion ≈ $397.66 Million	+16.52%
2022-12-31	₩503.59 Billion ≈ $341.28 Million	+4.72%
2021-12-31	₩480.89 Billion ≈ $325.89 Million	+21.82%
2020-12-31	₩394.74 Billion ≈ $267.51 Million	+20.94%
2019-12-31	₩326.40 Billion ≈ $221.20 Million	+16.32%
2018-12-31	₩280.60 Billion ≈ $190.16 Million	+2.44%
2017-12-31	₩273.91 Billion ≈ $185.63 Million	-4.71%
2016-12-31	₩287.45 Billion ≈ $194.80 Million	--

About Chong Kun Dang Pharmaceutical

KO:185750 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$765.24 Million

₩1.13 Trillion KRW

Market Cap Rank

#10377 Global

#308 in Korea

Share Price

₩85700.00

Change (1 day)

-1.38%

52-Week Range

₩78700.00 - ₩97700.00

All Time High

₩207617.05